The PDGFRB gene gives cells instructions for a surface protein that receives growth signals, especially in cells that support blood vessels and connective tissue. This gene helps your body build and repair tissues in a controlled way. If the gene works too little or too much, cells may grow or organize abnormally, which can affect blood vessels, bones, skin, or healing. Certain variants in the PDGFRB gene are linked to rare inherited conditions and, in some cases, to blood cancers.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some carry the directions for producing proteins, which are the working parts of cells. Others mainly guide when certain processes happen, where they take place, and how strongly they are active. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
PDGFRBGene function
What if the gene works
The PDGFRB gene helps certain cells sense growth signals. This supports blood vessel development, tissue repair, and the growth and movement of cells that help build and maintain connective tissues.
Risk
What if the gene does not work
PDGFRB variants can alter blood vessel and connective tissue signaling, causing infantile myofibromatosis or growth, skull, and limb changes. Milder and more severe variants can influence which features appear and how strongly.
Treatment
What does that mean for your treatment
Pathogenic changes involving the PDGFRB gene, especially gene fusions, can make the condition highly sensitive to tyrosine kinase inhibitors such as imatinib. This often guides treatment toward targeted therapy rather than standard chemotherapy alone, and many people have strong, lasting responses.
Conditions associated with PDGFRB
Gene function
What if the gene works
Your cells use the PDGFRB gene to receive growth signals from nearby cells. This is especially important in blood vessels and connective tissues, where cells need clear instructions about when to grow, move, and mature. Understanding what the PDGFRB gene does in the body helps explain how tissues develop and repair in an orderly way.
The PDGFRB gene makes a receptor on the cell surface that detects specific growth messages from nearby cells. It relays those messages inward so cells can adjust growth and activity in a controlled way.
Signals through this receptor help certain cells move to the places where they are needed. That movement supports normal tissue building, maintenance, and repair.
PDGFRB activity is especially important in cells that wrap around small blood vessels and support them. These signals help blood vessels mature and stay stable as tissues grow and renew.
This pathway helps guide immature cells toward more specialized support roles in tissues. That helps the body build structures with the right shape and strength.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the PDGFRB gene can change the shape or activity of a cell surface receptor, which helps explain how variants influence the PDGFRB gene's function. Some variants weaken signaling or make the receptor less stable, while others keep it switched on too easily and send growth signals at the wrong time. Variants that cause stronger overactivity are often linked to earlier or more marked features, while milder changes may have a smaller effect.
How variants are linked to conditions
Pathogenic variants in the PDGFRB gene cause several rare conditions. The main PDGFRB gene related conditions include infantile myofibromatosis, primary familial brain calcification, and less often rare growth conditions such as Penttinen syndrome and Kosaki overgrowth syndrome. When a clearly disease-causing PDGFRB variant is found in someone with matching features, it can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks linked to the PDGFRB gene. Risk usually depends most on the exact gene change and the condition involved, so people with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of PDGFRB variants
How PDGFRB variants are inherited depends on the condition, but the well-established pattern for known PDGFRB-related conditions is usually autosomal dominant. This means a person with a disease-causing variant in the PDGFRB gene has a 50% chance of passing it on to each child, regardless of sex. In some families, the variant is inherited from an affected parent. In other cases, it appears for the first time as a new de novo variant and is not inherited from either parent.
What does my PDGFRB result mean for my family?
A disease-causing change in the PDGFRB gene is usually linked to conditions that can run in families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. Some PDGFRB-related conditions start with a new gene change in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
PDGFRB genetic testing looks for variants in the PDGFRB gene using a blood sample, saliva, or sometimes cheek cells. A lab reads the gene’s DNA sequence to check for changes. Results can help confirm a condition linked to the PDGFRB gene or show whether a variant may help explain a person’s health findings or family history.
When should I consider getting a genetic test?
Consider PDGFRB testing if you or your child has multiple noncancerous growths in the skin, muscle, bone, or internal organs early in life, or if brain scans show calcium buildup that seems to run in the family. It may also help when doctors suspect a rare connective tissue or overgrowth condition linked to this gene.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Over time, how the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines and how strongly you respond to them. This helps explain why the same treatment may work well for one person, cause more side effects in another, or seem to have less effect in someone else. These differences are common and can reflect how the body absorbs, breaks down, moves, or responds to a drug.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By looking at connections between genes and drugs, it helps explain why treatment effects can differ from one person to another. For many medicines, genes influence both how the body processes a drug and how strongly that drug works. This information can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the PDGFRB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about medicines or side effects are best discussed with your doctor. In cancer care, PDGFRB changes in tumor cells can sometimes help doctors choose targeted treatment, so people living with a PDGFRB-related cancer may want to talk with their cancer team when treatment is being planned or changed.
History
The PDGFRB gene came into view during the late 1970s and 1980s, as scientists worked out how cells receive growth signals from platelet derived growth factor. Initially understood only through visible traits, later recognized as tied to a specific gene, this receptor became part of a broader wave of discoveries linking cell signaling to cancer biology. Building on this early work, scientists found that rearrangements involving the PDGFRB gene could drive certain blood cancers, which made it important in molecular diagnosis. Later studies connected variants in the PDGFRB gene with inherited conditions affecting blood vessels, bone growth, and soft tissue growth. Over time, descriptions became more precise, and the PDGFRB gene moved from a laboratory finding to a gene with clear clinical relevance.